Related Experiment Videos

First steps in the purification and characterization of a Pichia anomala killer toxin

C Guyard¹, N Séguy, M Lange

¹Dept. Microbiol. Ecosystèmes, Inst. Pasteur de Lille, France.

The Journal of Eukaryotic Microbiology

|October 16, 1999

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Evaluation of the inflammation-based modified Glasgow Prognostic Score (mGPS) as a prognostic and predictive biomarker in patients with metastatic colorectal cancer receiving first-line chemotherapy: a post hoc analysis of the randomized phase III XELAVIRI trial (AIO KRK0110).

ESMO open·2024

C-reactive protein monitoring after ileocecal resection and stoma closure reduces length of hospital stay: a prospective case-matched study in 410 patients with Crohn's disease.

Techniques in coloproctology·2022

Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial).

European journal of cancer (Oxford, England : 1990)·2018

Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer-central evaluation of FIRE-3.

European journal of cancer (Oxford, England : 1990)·2017

Evaluation of survival across several treatment lines in metastatic colorectal cancer: Analysis of the FIRE-3 trial (AIO KRK0306).

European journal of cancer (Oxford, England : 1990)·2017

Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group.

Annals of oncology : official journal of the European Society for Medical Oncology·2016

See all related articles